Rick Pauls is the President and Chief Executive Officer of DiaMedica Therapeutics, a biotechnology company focused on treating preeclampsia and acute.
Rick Pauls is the President and Chief Executive Officer of DiaMedica Therapeutics, a biotechnology company focused on treating preeclampsia and acute ischemic stroke. He has held the CEO role since at least November 2018, leading the company's clinical trials and capital strategy.
Full founder directory · Investor directory · Company funding database · Fundraising library